Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Progressive Relapsing Multiple Sclerosis”

129 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 129 results

Large-scale testing (Phase 3)UnknownNCT02220244
What this trial is testing

Effect of MD1003 in Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
MedDay Pharmaceuticals SA 105
Testing effectiveness (Phase 2)Ended earlyNCT01950234
What this trial is testing

ACTH in Progressive Forms of MS

Who this might be right for
Secondary Progressive Multiple SclerosisPrimary Progressive Multiple SclerosisProgressive Relapsing Multiple Sclerosis
University of Minnesota 59
Large-scale testing (Phase 3)Active Not RecruitingNCT04688788
What this trial is testing

Non-inferiority Study of Ocrelizumab and Rituximab in Active Multiple Sclerosis

Who this might be right for
Relapsing Remitting Multiple SclerosisSecondary Progressive Multiple SclerosisPrimary Progressive Multiple Sclerosis
Rigshospitalet, Denmark 600
Not applicableTemporarily pausedNCT04031469
What this trial is testing

A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease

Who this might be right for
Gut MicrobiomeGastrointestinal MicrobiomeAutism+77 more
ProgenaBiome 1,000
Large-scale testing (Phase 3)Study completedNCT01433497
What this trial is testing

Efficacy and Safety of Masitinib in the Treatment of Progressive Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Secondary ProgressiveMultiple Sclerosis, Primary ProgressiveMultiple Sclerosis, Relapse Free
AB Science 656
Testing effectiveness (Phase 2)Temporarily pausedNCT04909502
What this trial is testing

Evaluation of Safety, Tolerability and Preliminary Efficacy of EHP-101 in Relapsing Forms of Multiple Sclerosis

Who this might be right for
Relapsing Forms of Multiple Sclerosis
Emerald Health Pharmaceuticals 50
Not applicableUnknownNCT06516458
What this trial is testing

Development of Camera Based Gait Quality Measure for Persons With Multiple Sclerosis

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Secondary ProgressiveMultiple Sclerosis Relapse+1 more
Shirley Ryan AbilityLab 40
Not applicableStudy completedNCT05351411
What this trial is testing

Exercise on Contactin-1 and Contactin-2 Level in Persons With Multiple Sclerosis

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Firat University 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07222956
What this trial is testing

Remibrutinib Using MR Imaging in Relapsing or Progressive MS

Who this might be right for
Multiple Sclerosis (MS) - Relapsing-remittingMultiple Sclerosis (MS) Secondary ProgressiveMultiple Sclerosis (MS) Primary Progressive
Moein Amin 20
Not applicableUnknownNCT04260711
What this trial is testing

Discontinuing Disease-modifying Therapies in Stable Relapsing - Onset Multiple Sclerosis (DOT-MS).

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Secondary Progressive
Amsterdam UMC, location VUmc 130
Testing effectiveness (Phase 2)UnknownNCT00298662
What this trial is testing

Combination Therapy of Betaseron-Prograf in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Clinique de sclérose en plaques et neuromusculaire de l'Outaouais 30
Large-scale testing (Phase 3)Active Not RecruitingNCT05147220
What this trial is testing

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-1)

Who this might be right for
Relapsing Multiple Sclerosis
Novartis Pharmaceuticals 1,000
Large-scale testing (Phase 3)Study completedNCT04411641
What this trial is testing

Nonrelapsing Secondary Progressive Multiple Sclerosis (NRSPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (HERCULES)

Who this might be right for
Non-relapsing Secondary Progressive Multiple Sclerosis
Sanofi 1,131
Early research (Phase 1)Study completedNCT02506751
What this trial is testing

Open-label Study of Liothyronine in MS

Who this might be right for
Multiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Secondary ProgressiveMultiple Sclerosis, Primary Progressive
Johns Hopkins University 20
Not applicableStudy completedNCT02403570
What this trial is testing

Rotating Frame Relaxation Imaging in Patients With Multiple Sclerosis

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Chronic Progressive
Turku University Hospital 21
Early research (Phase 1)Ended earlyNCT01435993
What this trial is testing

Multiple Doses of Anti-NOGO A in Relapsing Forms of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
GlaxoSmithKline 3
Not applicableStudy completedNCT03134573
What this trial is testing

Medication Usage and Patient Reported Outcomes Evaluation Via myBETAapp in Patients With Multiple Sclerosis Treated With Betaferon: a Pilot Study

Who this might be right for
Multiple Sclerosis
Bayer 96
Early research (Phase 1)Not Yet RecruitingNCT07562074
What this trial is testing

Transcranial Magnetic Stimulation for Depression in Multiple Sclerosis

Who this might be right for
Multiple SclerosisDepression - Major Depressive DisorderFatigue
University of Calgary 20
Not applicableStudy completedNCT05663853
What this trial is testing

An Observational Biomarker Study in Multiple Sclerosis (MS) Patients

Who this might be right for
Multiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Primary ProgressiveMultiple Sclerosis, Secondary Progressive
LAPIX Therapeutics Inc. 137
Testing effectiveness (Phase 2)Study completedNCT05691192
What this trial is testing

Cognitive Reserve-building Activities in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Rigshospitalet, Denmark 60
Next Page